The European and the U.S. market for prebiotics is projected to reach nearly $1.2 billion and $225 million, respectively, by the year 2015, according to a new report from Global Industry Analysts (GIA).
Who says the natural products industry should decry drugs with OTC status? The opportunity for exploiting underappreciated weaknesses in the digestive health category, au naturel, is explosive.
Updated technologies and scientific research have opened up the pre/probiotics market to allow for different delivery forms and additional benefits beyond gut health.
Although the awareness and market value for probiotics, prebiotics and synbiotics is low, forthcoming research and novel delivery forms should provide a boost to the category.